U.S. markets close in 31 minutes

The Chugoku Electric Power Co., Inc. (CGKEY)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
25.32+25.32 (+0.00%)
As of 2:51PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close25.32
Open25.32
Bid0.00 x 0
Ask0.00 x 0
Day's Range25.32 - 25.32
52 Week Range25.32 - 25.32
Volume100
Avg. Volume0
Market Cap4.545B
Beta (5Y Monthly)0.06
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield0.93 (3.66%)
Ex-Dividend DateMar 27, 2020
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • BioSpecifics to Present at the Virtual Oppenheimer & Co. Fall Healthcare Life Sciences and MedTech Summit
      PR Newswire

      BioSpecifics to Present at the Virtual Oppenheimer & Co. Fall Healthcare Life Sciences and MedTech Summit

      BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first-in-class collagenase-based product marketed as XIAFLEX® in North America, today announced that Joseph Truitt, Chief Executive Officer, will present at the virtual Oppenheimer & Co. Fall Healthcare Life Sciences and MedTech Summit on Monday, September 21, 2020 at 4:10 p.m. ET.

    • BioSpecifics Technologies (BSTC) Has Risen 3% in Last One Year, Underperforms Market
      Insider Monkey

      BioSpecifics Technologies (BSTC) Has Risen 3% in Last One Year, Underperforms Market

      If you are looking for the best ideas for your portfolio you may want to consider some of Summers Value Partners top stock picks. Summers Value Partners, an investment management firm, is bullish on BioSpecifics Technologies Corp (NASDAQ:BSTC) stock. In its Q2 2019 investor letter – you can download a copy here – the firm […]

    • BioSpecifics to Present at the H.C. Wainwright Virtual Healthcare Conference
      PR Newswire

      BioSpecifics to Present at the H.C. Wainwright Virtual Healthcare Conference

      BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first-in-class collagenase-based product marketed as XIAFLEX® in North America, today announced that Joseph Truitt, Chief Executive Officer, will present at the H.C. Wainwright Virtual Healthcare Conference on Monday, September 14, 2020 at 3:00 p.m. ET.